Avidity Biosciences, Inc. (NASDAQ:RNA) has 333 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 3,648,222 | 39.64% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 429,491 | 3.25% | $0.00 |
| Avoro Capital Advisors LLC | 31 Dec, 2025 | 0 | 3,265,000 | 42.71% | $0.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Bellevue Group AG | 31 Dec, 2025 | 0 | 478,107 | 22.21% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -76,783 | -12.63% | $0.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 0 | -7,583,412 | -52.22% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 1,040,953 | 79.11% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | 65,458 | 0.00% | $0.00 |
| BALYASNY ASSET MANAGEMENT L.P. | 31 Dec, 2025 | 0 | 6,040,590 | 0.00% | $0.00 |
| Qube Research & Technologies Ltd | 31 Dec, 2025 | 0 | 1,105,830 | 0.00% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 565 | 147.52% | $0.00 |
| Pentwater Capital Management LP | 31 Dec, 2025 | 0 | 6,026,500 | 0.00% | $0.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 0 | 1,039,412 | 1,937.18% | $0.00 |
| HBK INVESTMENTS L P | 31 Dec, 2025 | 0 | 4,365,000 | 0.00% | $0.00 |
| KRYGER CAPITAL Ltd | 31 Dec, 2025 | 0 | 1,045,320 | 0.00% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | -790,747 | -16.18% | $0.00 |
| Frazier Life Sciences Management, L.P. | 31 Dec, 2025 | 0 | 358,125 | 57.30% | $0.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 0 | 2,044,316 | 118.00% | $0.00 |
| Man Group plc | 31 Dec, 2025 | 0 | 868,827 | 2,950.18% | $0.00 |